鉴定APBB1作为形淋巴瘤激酶的基质
Yuji Suzuki1,2, Shoma Tsubota2, Kenji Kadomatsu3
1Department of Integrative Physiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
Journal of biochemistry
|August 8, 2024
概括
研究人员确定了粉样β前体蛋白结合家族B成员1 (APBB1) 作为一种新型的形淋巴瘤激酶 (ALK) 基质. 这一发现增强了对神经母细胞瘤中ALK信号通路的理解.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 无细胞淋巴瘤激酶 (ALK) 是一种已知的瘤基因,涉及各种癌症,包括神经母细胞瘤.
- 虽然化ALK的基质已被记录,但缺乏对受体ALK基质的全面了解.
- 识别新型ALK基质对于阐明ALK在恶性瘤中的生物学作用至关重要.
研究的目的:
- 为了识别受体形淋巴瘤激酶 (ALK) 的新基质.
- 描述新发现的ALK基质的生物功能.
- 研究ALK信号传递在神经母细胞瘤细胞活力的作用.
主要方法:
- 使用靠近依赖生物素识别对受体ALK激酶域相互作用者的选.
- 在神经母细胞瘤细胞系 (NB-1) 中验证ALK下游分子.
- 细胞内和管内激酶基质测试以评估已识别基质的ALK酸化.
主要成果:
- 确定了43个潜在的ALK相互作用体.
- 确认了粉样β前体蛋白结合家族B成员1 (APBB1) 作为影响NB-1细胞活力的ALK下游分子.
- 证明ALK在APBB1中酸化多重的铁氨酸残留物,其主要部位位于铁氨酸269.
结论:
- 成功识别了APBB1作为ALK受体的新型基质.
- 这些发现为ALK在神经母细胞瘤下游信号传导机制提供了新的见解.
- 这项研究有助于更深入地了解ALK在瘤发生中的作用.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


